Evonik Industries, one of the world’s leading suppliers of methacrylate chemicals, will raise the prices of its VISIOMER® Methacrylate Monomers.
The new pricing structure applies to customers in the Asia Pacific region.
Effective March 15, 2011, as far as permissible under existing agreements, the prices will be increased by the levels indicated below:
VISIOMER® Methyl Methacrylate + 200 $ / mt
VISIOMER® Methacrylic Acid + 250 $ / mt
VISIOMER® Butyl Methacrylate + 300 $ / mt
VISIOMER® Hydroxy Esters + 300 $ / mt
VISIOMER® Application Monomers + 300 $ / mt
The price increase is caused by massive changes of raw material costs.
Evonik Industries is the creative industrial group from Germany. In our core business of specialty chemicals, we are a global leader. In addition, Evonik is an expert in power generation from hard coal and renewable energies, and one of the largest private residential real estate companies in Germany. Our company’s performance is shaped by creativity, specialization, continuous self-renewal, and reliability. Evonik is active in over 100 countries around the world. In its fiscal
year 2009 about 39,000 employees generated sales of about €13.1 billion and an operating profit (EBITDA) of about €2.0 billion.
Evonik Industries has been producing specialty chemical products in China since the early 1990’s; with wide-ranging trading relations already in place prior to this. The Group now has a total of 20 companies and 16 production sites in the Greater China region. Evonik regards China as one of the driving forces of the global economy, and we consequently intend to increase our business in Greater China to around €2 billion by 2015.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.